Cetuximab

Results: 236



#Item
1References [1] R. A. Adams, A. M. Meade, A. Madi, D. Fisher, E. Kay, S. Kenny, R. S. Kaplan, and T. S. Maughan. Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC

References [1] R. A. Adams, A. M. Meade, A. Madi, D. Fisher, E. Kay, S. Kenny, R. S. Kaplan, and T. S. Maughan. Toxicity associated with combination oxaliplatin plus fluoropyrimidine with or without cetuximab in the MRC

Add to Reading List

Source URL: www.toumiak.com

Language: English - Date: 2016-07-02 18:03:03
2ICECREAM: Cetuximab antibody treatment for colorectal cancer with a G13D gene mutation The ICECREAM trial has helped researchers answer an important health question. It has provided evidence that cetuximab alone is not a

ICECREAM: Cetuximab antibody treatment for colorectal cancer with a G13D gene mutation The ICECREAM trial has helped researchers answer an important health question. It has provided evidence that cetuximab alone is not a

Add to Reading List

Source URL: www.ctc.usyd.edu.au

Language: English - Date: 2016-04-26 01:43:08
3Translating Genomes | Personalizing Medicine rAAV human gene editing, isogenic human disease models, phenotypic cellbased assays for precision functional genomics and targeted drug discovery  400 peer reviewed publica

Translating Genomes | Personalizing Medicine rAAV human gene editing, isogenic human disease models, phenotypic cellbased assays for precision functional genomics and targeted drug discovery  400 peer reviewed publica

Add to Reading List

Source URL: www.summitpharma.co.jp

Language: English - Date: 2013-03-28 07:55:46
4PAN01 biomarker poster ESMO 15.pdf

PAN01 biomarker poster ESMO 15.pdf

Add to Reading List

Source URL: www.ctueoc.ch

Language: English - Date: 2016-08-08 11:30:22
5ATTAX3: Panitumumab added to docetaxel, cisplatin, fluoropyrimidine in oesophagogastric cancer The ATTAX3 trial has helped researchers answer an important health question. It has provided evidence on the value of a new c

ATTAX3: Panitumumab added to docetaxel, cisplatin, fluoropyrimidine in oesophagogastric cancer The ATTAX3 trial has helped researchers answer an important health question. It has provided evidence on the value of a new c

Add to Reading List

Source URL: www.ctc.usyd.edu.au

Language: English - Date: 2016-02-25 18:33:39
6HHS Public Access Author manuscript Author Manuscript Cancer Discov. Author manuscript; available in PMC 2016 January 01. Published in final edited form as:

HHS Public Access Author manuscript Author Manuscript Cancer Discov. Author manuscript; available in PMC 2016 January 01. Published in final edited form as:

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
7An array of opportunities for translational research r ce n ca t i‐ u g s

An array of opportunities for translational research r ce n ca t i‐ u g s

Add to Reading List

Source URL: www.oncodesign.fr

Language: English - Date: 2012-12-05 06:25:30
8An array of opportunities for translational research r ce n ca t i‐ u g s

An array of opportunities for translational research r ce n ca t i‐ u g s

Add to Reading List

Source URL: www.oncodesign.com

Language: English - Date: 2012-12-05 06:25:30
9Second-line cetuximab active beyond progression in quadruple wild-type patients with mCRC

Second-line cetuximab active beyond progression in quadruple wild-type patients with mCRC

Add to Reading List

Source URL: medicalxpress.com

Language: English - Date: 2016-03-03 01:12:52
    10Cetuximab/ FLIRI (Irinotekan/FLV) (colorektal) Cetuximab Irinotekan 5-Fluorouracil Calciumfolinat

    Cetuximab/ FLIRI (Irinotekan/FLV) (colorektal) Cetuximab Irinotekan 5-Fluorouracil Calciumfolinat

    Add to Reading List

    Source URL: www.cancercentrum.se

    - Date: 2012-11-02 03:52:23